Michael Gasser

899 total citations
24 papers, 601 citations indexed

About

Michael Gasser is a scholar working on Applied Microbiology and Biotechnology, Clinical Biochemistry and Molecular Medicine. According to data from OpenAlex, Michael Gasser has authored 24 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Applied Microbiology and Biotechnology, 8 papers in Clinical Biochemistry and 8 papers in Molecular Medicine. Recurrent topics in Michael Gasser's work include Antibiotic Use and Resistance (14 papers), Antibiotic Resistance in Bacteria (8 papers) and Bacterial Identification and Susceptibility Testing (8 papers). Michael Gasser is often cited by papers focused on Antibiotic Use and Resistance (14 papers), Antibiotic Resistance in Bacteria (8 papers) and Bacterial Identification and Susceptibility Testing (8 papers). Michael Gasser collaborates with scholars based in Switzerland, France and United States. Michael Gasser's co-authors include Barbara Rothen‐Rutishauser, Peter Gehr, Fabian Blank, I. Odler, Michael Riediker, Loretta Mueller, Andreas Kronenberg, Bing Yan, Harald F. Krug and Peter Wick and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of the American Ceramic Society.

In The Last Decade

Michael Gasser

22 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Gasser Switzerland 12 149 142 112 84 74 24 601
Zhongwei Yang China 17 180 1.2× 288 2.0× 19 0.2× 321 3.8× 46 0.6× 66 1.4k
Minna M. Keinänen‐Toivola Finland 9 113 0.8× 113 0.8× 3 0.0× 110 1.3× 46 0.6× 14 530
Chane-Yu Lai Taiwan 14 175 1.2× 46 0.3× 24 0.2× 55 0.7× 308 4.2× 29 677
Peter Bottenberg Belgium 20 48 0.3× 20 0.1× 13 0.1× 108 1.3× 23 0.3× 77 1.9k
Navideh Abbasnezhad France 11 43 0.3× 51 0.4× 29 0.3× 105 1.3× 191 2.6× 20 558
Jingjing Zhao China 20 4 0.0× 93 0.7× 75 0.7× 224 2.7× 9 0.1× 55 1.6k
Nader Zirak France 10 43 0.3× 44 0.3× 80 0.7× 117 1.4× 188 2.5× 16 520
Shovon Bhattacharjee Australia 16 28 0.2× 153 1.1× 15 0.1× 247 2.9× 191 2.6× 30 784
Yoav Finer Canada 27 39 0.3× 50 0.4× 52 0.5× 274 3.3× 29 0.4× 62 2.4k
Hironao Ogura Japan 22 57 0.4× 263 1.9× 9 0.1× 398 4.7× 21 0.3× 94 1.6k

Countries citing papers authored by Michael Gasser

Since Specialization
Citations

This map shows the geographic impact of Michael Gasser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Gasser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Gasser more than expected).

Fields of papers citing papers by Michael Gasser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Gasser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Gasser. The network helps show where Michael Gasser may publish in the future.

Co-authorship network of co-authors of Michael Gasser

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Gasser. A scholar is included among the top collaborators of Michael Gasser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Gasser. Michael Gasser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Grant, Rebecca, et al.. (2025). Incidence and Resistance Patterns of Citrobacter spp. in Switzerland: A Nationwide, Retrospective Surveillance Study (2010–2022). Microorganisms. 13(4). 786–786. 2 indexed citations
3.
Gasser, Michael, et al.. (2024). Post-pandemic consumption of outpatient antibiotics in Switzerland up to pre-pandemic levels, 2018–2023: An interrupted time series analysis. SHILAP Revista de lepidopterología. 1(2). 105037–105037.
4.
Damonti, Lauro, Michael Gasser, Andreas Kronenberg, & Niccolò Buetti. (2024). Epidemiology of bloodstream infections caused by extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae in Switzerland, 2015–2022: secular trends and association with the COVID-19 pandemic. Journal of Hospital Infection. 150. 145–152. 3 indexed citations
5.
Gasser, Michael, et al.. (2023). Assessing the conversion of electronic medical record data into antibiotic stewardship indicators. Journal of Antimicrobial Chemotherapy. 78(9). 2297–2305. 2 indexed citations
6.
7.
8.
9.
Gasser, Michael, Alexia Cusini, Rosamaria Fulchini, et al.. (2022). Impact of the COVID-19 Pandemic on Inpatient Antibiotic Consumption in Switzerland. Antibiotics. 11(6). 792–792. 20 indexed citations
10.
Baty, Florent, Werner C. Albrich, Baharak Babouee Flury, et al.. (2021). Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018. Eurosurveillance. 26(46). 24 indexed citations
11.
Damonti, Lauro, Andreas Kronenberg, Jonas Marschall, et al.. (2021). The effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: a nationwide surveillance study. Critical Care. 25(1). 403–403. 10 indexed citations
12.
Gasser, Michael, et al.. (2021). Consumption of anti-meticillin-resistant Staphylococcus aureus antibiotics in Swiss hospitals is associated with antibiotic stewardship measures. Journal of Hospital Infection. 117. 165–171. 7 indexed citations
13.
Gasser, Michael, et al.. (2021). Temporal and structural patterns of extended-spectrum cephalosporin-resistant Klebsiella pneumoniae incidence in Swiss hospitals. Journal of Hospital Infection. 120. 36–42. 6 indexed citations
14.
Sommerstein, Rami, Lauro Damonti, Jonas Marschall, et al.. (2021). Distribution of pathogens and antimicrobial resistance in ICU-bloodstream infections during hospitalization: a nationwide surveillance study. Scientific Reports. 11(1). 13 indexed citations
15.
Ramette, Alban, Michael Gasser, Patrice Nordmann, et al.. (2021). Temporal and regional incidence of carbapenemase-producing Enterobacterales, Switzerland, 2013 to 2018. Eurosurveillance. 26(15). 15 indexed citations
16.
Piezzi, Vanja, Michael Gasser, Andrew Atkinson, et al.. (2020). Increasing proportion of vancomycin resistance among enterococcal bacteraemias in Switzerland: a 6-year nation-wide surveillance, 2013 to 2018. Eurosurveillance. 25(35). 15 indexed citations
17.
Gasser, Michael, Peter Wick, Martin J. D. Clift, et al.. (2012). Pulmonary surfactant coating of multi-walled carbon nanotubes (MWCNTs) influences their oxidative and pro-inflammatory potential in vitro. Particle and Fibre Toxicology. 9(1). 17–17. 74 indexed citations
18.
Gasser, Michael, Barbara Rothen‐Rutishauser, Harald F. Krug, et al.. (2010). The adsorption of biomolecules to multi-walled carbon nanotubes is influenced by both pulmonary surfactant lipids and surface chemistry. Journal of Nanobiotechnology. 8(1). 31–31. 81 indexed citations
19.
Gasser, Michael, Michael Riediker, Loretta Mueller, et al.. (2009). Toxic effects of brake wear particles on epithelial lung cells in vitro. Particle and Fibre Toxicology. 6(1). 30–30. 164 indexed citations
20.
Odler, I. & Michael Gasser. (1988). Mechanism of Sulfate Expansion in Hydrated Portland Cement. Journal of the American Ceramic Society. 71(11). 1015–1020. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhongwei Yang Breakdown of academic impact, for papers by Minna M. Keinänen‐Toivola Breakdown of academic impact, for papers by Chane-Yu Lai Breakdown of academic impact, for papers by Peter Bottenberg Breakdown of academic impact, for papers by Navideh Abbasnezhad Breakdown of academic impact, for papers by Jingjing Zhao Breakdown of academic impact, for papers by Nader Zirak Breakdown of academic impact, for papers by Shovon Bhattacharjee Breakdown of academic impact, for papers by Yoav Finer Breakdown of academic impact, for papers by Hironao Ogura
Rankless by CCL
2026